OBJECTIVE: To determine whether low mannan-binding lectin (MBL) and C4A null alleles (C4AQ0) are associated with systemic lupus erythematosus (SLE) in multicase families with SLE. METHODS: Low MBL level was determined by measuring serum levels and by genotyping for mutant structural (B/C/D, designated as 0) and promoter (LX) alleles (by real-time polymerase chain reaction). C4AQ0 was detected by protein electrophoresis and corroborated with haplotype and genotype analysis. In nine Icelandic families, 24 patients with SLE were compared with 83 first-degree and 23 second-degree relatives without SLE. Twenty four unrelated family members and a population group of 330 Icelanders served as controls. RESULTS: Overall, the frequency of low MBL genotypes (0/0, LX/0 and wild-type/0) tended to be higher in patients with SLE than in their first-degree and second-degree relatives (p = 0.06), but the frequency was similar in the families and in the controls (p = 0.6). The frequency of C4AQ0 was, however, increased in patients and their relatives compared with that in the controls (p = 0.04). The combination of low MBL genotypes and C4AQ0 was found more often in the patients than in their relatives (p = 0.03) and controls (p = 0.02). However, low MBL level was observed only in patients and first-degree relatives in five of the nine multicase families. In these five families, patients with SLE had low MBL genotypes more often (64%) than their first-degree (38%) and second-degree (0%) relatives (p = 0.001), and the patients with SLE also had, accordingly, lower MBL levels than their relatives (p = 0.001). CONCLUSIONS: These findings indicate that low MBL levels can predispose people to SLE and highlight the genetic heterogeneity of this disease.
OBJECTIVE: To determine whether low mannan-binding lectin (MBL) and C4A null alleles (C4AQ0) are associated with systemic lupus erythematosus (SLE) in multicase families with SLE. METHODS: Low MBL level was determined by measuring serum levels and by genotyping for mutant structural (B/C/D, designated as 0) and promoter (LX) alleles (by real-time polymerase chain reaction). C4AQ0 was detected by protein electrophoresis and corroborated with haplotype and genotype analysis. In nine Icelandic families, 24 patients with SLE were compared with 83 first-degree and 23 second-degree relatives without SLE. Twenty four unrelated family members and a population group of 330 Icelanders served as controls. RESULTS: Overall, the frequency of low MBL genotypes (0/0, LX/0 and wild-type/0) tended to be higher in patients with SLE than in their first-degree and second-degree relatives (p = 0.06), but the frequency was similar in the families and in the controls (p = 0.6). The frequency of C4AQ0 was, however, increased in patients and their relatives compared with that in the controls (p = 0.04). The combination of low MBL genotypes and C4AQ0 was found more often in the patients than in their relatives (p = 0.03) and controls (p = 0.02). However, low MBL level was observed only in patients and first-degree relatives in five of the nine multicase families. In these five families, patients with SLE had low MBL genotypes more often (64%) than their first-degree (38%) and second-degree (0%) relatives (p = 0.001), and the patients with SLE also had, accordingly, lower MBL levels than their relatives (p = 0.001). CONCLUSIONS: These findings indicate that low MBL levels can predispose people to SLE and highlight the genetic heterogeneity of this disease.
Authors: H Kristjánsdóttir; K Bjarnadóttir; I B Hjálmarsdóttir; G Gröndal; A Arnason; K Steinsson Journal: J Rheumatol Date: 2000-11 Impact factor: 4.666
Authors: Young Ho Lee; Torsten Witte; Tanja Momot; Reinhold E Schmidt; Kenneth M Kaufman; John B Harley; Andrea L Sestak Journal: Arthritis Rheum Date: 2005-12
Authors: A K Lindqvist; K Steinsson; B Johanneson; H Kristjánsdóttir; A Arnasson; G Gröndal; I Jonasson; V Magnusson; G Sturfelt; L Truedsson; E Svenungsson; I Lundberg; J D Terwilliger; U B Gyllensten; M E Alarcón-Riquelme Journal: J Autoimmun Date: 2000-03 Impact factor: 7.094
Authors: R Takahashi; A Tsutsumi; K Ohtani; Y Muraki; D Goto; I Matsumoto; N Wakamiya; T Sumida Journal: Ann Rheum Dis Date: 2005-02 Impact factor: 19.103
Authors: A Troldborg; S Thiel; L Jensen; S Hansen; M J Laska; B Deleuran; J C Jensenius; K Stengaard-Pedersen Journal: Clin Exp Immunol Date: 2015-08-31 Impact factor: 4.330
Authors: Saedis Saevarsdottir; Bo Ding; Kristjan Steinsson; Gerdur Grondal; Helgi Valdimarsson; Lars Alfredsson; Lars Klareskog; Leonid Padyukov Journal: Arthritis Res Ther Date: 2011-04-15 Impact factor: 5.156
Authors: Richard K Albert; John Connett; Jeffrey L Curtis; Fernando J Martinez; Meilan K Han; Stephen C Lazarus; Prescott G Woodruff Journal: Int J Chron Obstruct Pulmon Dis Date: 2012-11-23
Authors: Damon P Eisen; Melinda M Dean; Marja A Boermeester; Katy J Fidler; Anthony C Gordon; Gitte Kronborg; Jürgen F J Kun; Yu Lung Lau; Antonis Payeras; Helgi Valdimarsson; Stephen J Brett; W K Eddie Ip; Joan Mila; Mark J Peters; Saedis Saevarsdottir; J W Oliver van Till; Charles J Hinds; Emma S McBryde Journal: Clin Infect Dis Date: 2008-08-15 Impact factor: 9.079